HIGHLIGHTS
- What: The aim was to identify the specific patient signatures that may better benefit of a specific therapeutic approach . The analysis showed p53 activation signatures in tumors with PNI compared to those without.
- Who: Martina Catalano from the Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy have published the paper: Management Approaches for High-Risk Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Updated Review, in the Journal: (JOURNAL)
- Future: Prospective comparative studies are required to comprehensively evaluate the benefit and the risks of ART for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.